Skip to content

Medical-device intelligence

PGI: Herpes Virus (Vzv, Hsv1, Hsv2), Dna Detection Assay For Cutaneous And Mucocutaneous Lesion Samples

FDA product code PGI: Herpes Virus (Vzv, Hsv1, Hsv2), Dna Detection Assay For Cutaneous And Mucocutaneous Lesion Samples. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
PGI
FDA device name
Herpes Virus (Vzv, Hsv1, Hsv2), Dna Detection Assay For Cutaneous And Mucocutaneous Lesion Samples
Device class
2
Regulation number
866.3309
Medical specialty
Microbiology
Review panel
MI

FDA definition

For the qualitative detection and differentiation of VZV, HSV1, HSV2- DNA in cutaneous and mucocutaneous lesion samples from symptomatic patients. The assay is not intended for use with cerebral spinal fluid.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

8 clearance records and 2 recall records in the covered releases, across 6 source company names and 1 product codes. Dated history runs from Jul 17, 2015 to May 3, 2024.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

10 matching records
Device / recordCompany in FDA recordSourceSource date
Alinity m HSV 1 & 2 / VZVK233349 · PGIAbbott Molecular, Inc.510(k)May 3, 2024FDA decision date
Savanna HSV 1+2/VZV Assay, Savanna HSV 1+2/VZV Control Set, Savanna InstrumentK232286 · PGIQuidel Corporation510(k)Dec 20, 2023FDA decision date
MOL3655 Simplexa VZV Swab Direct - Product Usage: is intended for use on the LIAISON MDX instrument for the qualitative detection of varicella-zo…Z-2549-2020 · PGIDiaSorin Molecular LLCRecallJul 10, 2020FDA classification date
Simplexa VZV Swab Direct, Simplexa VZV Positive Control PackK192376 · PGIDiasorin Molecular, LLC510(k)Nov 26, 2019FDA decision date
ARIES HSV 1&2 Assay , REF 50-10017, UDI # 00840487100295Z-2283-2019 · PGILuminex CorporationRecallAug 15, 2019FDA classification date
HSV 1 & 2 ELITe MGB Kit; ELITe InGeniusK180559 · PGIElitechgroup510(k)Oct 29, 2018FDA decision date
Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control PackK173798 · PGIDiasorin Molecular, LLC510(k)Mar 14, 2018FDA decision date
Solana HSV 1+2/VZV AssayK162451 · PGIQuidel Corporation510(k)Nov 28, 2016FDA decision date
ARIES HSV 1&2 Assay Cassettes - Carton of 24 (IVD), ARIES HSV 1&2 Assay Protocol File Kit (IVD), ARIES HSV 1&2 Assay Cassette (IVD)K151906 · PGILuminex Corporation510(k)Oct 6, 2015FDA decision date
illumigene HSV 1&2 DNA Amplification Assay, illumigene HSV 1&2 External Control Kit, illumipro-10K151046 · PGIMeridian Bioscience, Inc.510(k)Jul 17, 2015FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗